By Dr. Vishal Saini, M.D., FAASM — Mid-West Center for Sleep Disorders
Patients often assume all the "mask machines" are basically the same device with different labels. They are not. A standard CPAP and an adaptive servo-ventilation (ASV) unit share a mask and a hose, but under the hood they solve two different problems in two entirely different ways. One holds a door open. The other is a thermostat that adjusts, breath by breath, to keep your breathing steady. Understanding that distinction matters — because for the right patient it's the difference between a therapy that works and one that can't, and because for the wrong patient, ASV carries a safety risk serious enough that it can never simply be shipped to your door.
Let me walk through it the way I would in clinic.
First, What CPAP and Auto-CPAP Actually Do
CPAP — continuous positive airway pressure — treats obstructive sleep apnea with a beautifully simple idea: a steady stream of pressurized air acts as a pneumatic splint, holding the floppy tissues of your throat open so the airway can't collapse while you sleep. That's it. It keeps the pipe open. You still do all the breathing.
Auto-CPAP (APAP) is a smarter version of the same idea. Instead of one fixed pressure all night, it delivers a single pressure that automatically nudges up and down within a set range, moment to moment, in response to signs of trouble — snoring, airflow limitation, the beginnings of a collapse. When it senses your airway starting to narrow, it raises the pressure just enough to prop it back open; when things are calm, it eases off. It's an elegant, self-adjusting splint, and for the large majority of people with straightforward obstructive sleep apnea, it's exactly the right tool.
But notice the crucial limitation buried in that description: auto-CPAP is passive. It keeps the airway open and then trusts your brain and lungs to keep breathing. It has one lever — pressure to prevent obstruction — and one job: keep the pipe from collapsing.
"CPAP is a pneumatic splint. It's superb at keeping a floppy airway open. What it cannot do is make you take a breath — and for some patients, that's precisely the problem that needs solving." — Dr. Vishal Saini
Where Auto-CPAP Runs Out of Road
To see why some patients need more, you have to know that not all apneas are the same.
- In an obstructive apnea, your airway closes but your brain and chest are still trying to breathe — the effort is there, the pipe is blocked. CPAP fixes this perfectly.
- In a central apnea, the airway is open, but your brain briefly stops sending the signal to breathe at all. There is no effort to assist. The pause isn't a plumbing problem; it's a signaling problem.
CPAP is powerless against a central event. You cannot splint your way out of a missing breath — and cranking the pressure higher does nothing for a central pause and can sometimes make breathing more unstable.
Central and unstable breathing show up in several important situations:
- Cheyne-Stokes respiration — a rhythmic, waxing-and-waning "crescendo–decrescendo" breathing pattern with recurring central pauses, classically seen in heart failure and after some strokes.
- Idiopathic central sleep apnea, where the breathing control system is simply unstable on its own.
- Treatment-emergent central sleep apnea (also called complex sleep apnea) — central events that appear or persist after CPAP is started, in a patient who looked purely obstructive at first.
- Opioid-associated central apnea, a well-recognized effect of chronic opioid therapy on the brain's breathing centers.
In all of these, an auto-CPAP can keep the airway open flawlessly and still leave the patient with a stream of untreated central events — sometimes a perfectly "compliant" CPAP download that still shows a stubbornly high central apnea index. That's the wall auto-CPAP hits.
What VPAP-ASV Is — and Why It's a Different Class of Machine
VPAP is ResMed's name for its bilevel (variable positive airway pressure) devices, and ASV — adaptive servo-ventilation — is the most sophisticated mode in that family. Where CPAP has one pressure lever, ASV has three coordinated tools working together:
-
1. Expiratory pressure (EPAP), often auto-adjusting. This is the CPAP-like job: a baseline pressure that splints the airway open and handles the obstructive component, exactly as auto-CPAP would.
-
2. Servo-controlled pressure support. On top of EPAP, the device adds extra pressure during each inhalation — and here is the magic: that boost is not fixed. The machine continuously measures your own recent breathing and sets a moving target for how much air you should be moving. Then, in real time:
- when your breathing fades — the trough of a Cheyne-Stokes cycle, or the start of a central pause — it increases the pressure support to keep air flowing, effectively breathing for you until your own drive returns;
- when your breathing surges — the overshoot at the peak of the cycle — it backs off, so it doesn't amplify the instability.
This is the "servo" in servo-ventilation: a feedback loop that actively smooths the waxing-and-waning pattern that drives central apnea, second by second.
-
3. A backup respiratory rate. If you simply don't take a breath in time, ASV delivers a mandatory, timed breath of its own. A CPAP has no such backup — it will never breathe on your behalf. ASV will.
Put those together and the fundamental difference becomes clear. Auto-CPAP is a passive splint that targets an open airway. VPAP-ASV is an active, adaptive ventilator that targets stable breathing itself — continuously sensing your ventilation and modulating pressure to hold it steady, obstructive events and central events alike.
A useful analogy: cruise control vs. adaptive cruise control
Auto-CPAP is like ordinary cruise control: it adjusts the throttle to maintain one thing — in this case, an open airway. VPAP-ASV is like adaptive cruise control that watches the car ahead and constantly modulates speed to hold a safe, steady distance: it eases off when you're moving too much air and steps in (even "accelerating" with a backup breath) when you're moving too little. One holds a setting. The other continuously reacts to keep you stable.
Auto-CPAP vs. VPAP-ASV at a Glance
| Auto-CPAP (APAP) | VPAP-ASV | |
|---|---|---|
| Pressure delivered | One self-adjusting pressure | Baseline EPAP plus variable, servo-controlled pressure support |
| What it targets | An open airway | Stable ventilation (your own moving average) |
| How it responds | To signs of obstruction/flow limitation | To breath-by-breath changes in your breathing |
| Backup breath? | No | Yes — a timed backup rate |
| Nature of therapy | Passive pneumatic splint | Active, adaptive ventilation |
| Best suited for | Obstructive sleep apnea | Central, complex, and Cheyne-Stokes breathing |
| How it's set up | Often auto-titrating at home | Usually an attended in-lab titration |
Who Actually Needs ASV — and the Safety Line That Governs Everything
ASV is the treatment of choice for the breathing patterns auto-CPAP can't stabilize: idiopathic central sleep apnea, Cheyne-Stokes respiration, treatment-emergent/complex central sleep apnea that persists on CPAP, and (in selected cases) opioid-associated central apnea. Typically we reach for it after CPAP has been tried and the central component won't come under control.
But sophistication cuts both ways, and this is the most important part of the article. ASV is not appropriate for everyone with central apnea — and in one specific group it is outright contraindicated because it can cause harm.
In the landmark SERVE-HF trial, patients with symptomatic chronic heart failure and a reduced ejection fraction (LVEF of 45% or less) and predominantly central sleep apnea were randomized to ASV or usual care. ASV did not improve the main outcome — and, alarmingly, both all-cause mortality (hazard ratio 1.28) and cardiovascular mortality (hazard ratio 1.34) were significantly higher in the ASV group (Cowie et al., New England Journal of Medicine, 2015, PMID 26323938). As a direct result, ASV is now contraindicated in patients with symptomatic heart failure with reduced ejection fraction and predominant central sleep apnea. That is why every patient considered for ASV needs their heart function assessed — usually an echocardiogram to measure ejection fraction — before the device is ever prescribed.
There is important nuance that came later. The ADVENT-HF trial studied a broader population of heart-failure patients with sleep-disordered breathing and found that ASV "had no effect on the primary composite outcome or mortality but eliminated sleep-disordered breathing safely" (Bradley et al., Lancet Respiratory Medicine, 2024, PMID 38142697) — no mortality signal in that wider group. Taken together, the two trials tell us the danger was specific to the SERVE-HF phenotype — reduced-EF heart failure with predominant central apnea — rather than a flaw in ASV itself. But the contraindication for that phenotype is firm, and it is the reason ASV demands careful patient selection.
"The exact feature that makes ASV powerful — that it actively drives ventilation — is also what makes it dangerous in the wrong heart. This is a therapy that must be matched to the right patient by a physician who has checked the heart first, not one that can be handed out from an algorithm." — Dr. Vishal Saini
Why ASV Belongs in a Real Sleep Practice, Not a Mail-Order Pathway
Everything above explains why ASV is one of the clearest examples of care that cannot be reduced to an online test and a shipped machine. Prescribing it responsibly requires several things a mail-order model doesn't provide: a diagnostic study that actually distinguishes central from obstructive events; a cardiac evaluation, including ejection fraction, to make sure the patient isn't in the contraindicated group; and — in almost all cases — an attended, in-laboratory titration, where a technologist and physician dial in the baseline pressure, the limits of pressure support, and the backup rate, and watch how your breathing responds in real time. Then there's the ongoing management as your condition (or your heart) changes. A single-pressure auto-CPAP can often be started from home. An ASV device is a supervised, individualized therapy from start to finish.
The Bottom Line
Auto-CPAP and VPAP-ASV look alike and do fundamentally different things. Auto-CPAP is a smart, self-adjusting splint that keeps your airway open — the right answer for ordinary obstructive sleep apnea, and nothing more is needed. ASV is an adaptive ventilator that actively stabilizes your breathing, adding a variable, servo-controlled boost and a backup breath to smooth out the central and Cheyne-Stokes patterns that CPAP simply can't touch. That makes ASV far more sophisticated — and also far more consequential: it must be matched to the right patient, kept away from the reduced-EF heart-failure phenotype it can harm, and dialed in and monitored by a sleep team. If you've been told standard CPAP isn't controlling your central events, ASV may be exactly what you need. And if you've been told you need ASV, understand that the extra steps and the in-lab titration aren't red tape — they're the safeguards that make a powerful therapy a safe one.
Dr. Vishal Saini, M.D., FAASM is the Research & Medical Director at Mid-West Center for Sleep Disorders, which operates its own sleep laboratory and performs attended PAP and ASV titrations. He evaluates and treats obstructive, central, and complex sleep apnea, insomnia, narcolepsy, and hypersomnia disorders in Lansing, Traverse City, and Eaton Rapids.
Told that CPAP isn't controlling your central events, or that you may need ASV? Let's evaluate it properly — including the heart.
Book a Consultation → | (517) 887-6733
References: Cowie MR, Woehrle H, Wegscheider K, et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure (SERVE-HF). N Engl J Med 2015;373:1095–1105 (PMID 26323938); Bradley TD, Logan AG, Lorenzi Filho G, et al. Adaptive servo-ventilation for sleep-disordered breathing in patients with heart failure with reduced ejection fraction (ADVENT-HF): a multicentre, phase 3 randomised controlled trial. Lancet Respir Med 2024 (PMID 38142697). ASV indications and the reduced-EF heart-failure contraindication reflect American Academy of Sleep Medicine guidance and device-manufacturer field safety notices issued after SERVE-HF.